Literature DB >> 11515807

Nitric oxide in immunity and inflammation.

J W Coleman1.   

Abstract

Nitric oxide (NO) is synthesised by many cell types involved in immunity and inflammation. The principal enzyme involved is the inducible type-2 isoform of nitric oxide synthase (NOS-2), which produces high-level sustained NO synthesis. NO is important as a toxic defense molecule against infectious organisms. It also regulates the functional activity, growth and death of many immune and inflammatory cell types including macrophages, T lymphocytes, antigen-presenting cells, mast cells, neutrophils and natural killer cells. However, the role of NO in nonspecific and specific immunity in vivo and in immunologically mediated diseases and inflammation is poorly understood. NO does not act through a receptor-its target cell specificity depends on its concentration, its chemical reactivity, the vicinity of target cells and the way that target cells are programmed to respond. At high concentrations as generated by NOS-2, NO is rapidly oxidised to reactive nitrogen oxide species (RNOS) that mediate most of the immunological effects of NOS-2-derived NO. RNOS can S-nitrosate thiols to modify key signalling molecules such as kinases and transcription factors. Several key enzymes in mitochondrial respiration are also inhibited by RNOS and this leads to a depletion of ATP and cellular energy. A combination of these interactions may explain the multiple actions of NO in the regulation of immune and inflammatory cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11515807     DOI: 10.1016/s1567-5769(01)00086-8

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  176 in total

Review 1.  Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation.

Authors:  J W Coleman
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

2.  Diagnostic tools in Rhinology EAACI position paper.

Authors:  Glenis Scadding; Peter Hellings; Isam Alobid; Claus Bachert; Wytske Fokkens; Roy Gerth van Wijk; Philippe Gevaert; Josep Guilemany; Livije Kalogjera; Valerie Lund; Joaquim Mullol; Giovanni Passalacqua; Elina Toskala; Cornelius van Drunen
Journal:  Clin Transl Allergy       Date:  2011-06-10       Impact factor: 5.871

3.  Involvement of purinergic signaling on nitric oxide production by neutrophils stimulated with Trichomonas vaginalis.

Authors:  Amanda Piccoli Frasson; Geraldo Attilio De Carli; Carla Denise Bonan; Tiana Tasca
Journal:  Purinergic Signal       Date:  2011-08-11       Impact factor: 3.765

4.  Helminth regulation of host IL-4Ralpha/Stat6 signaling: mechanism underlying NOS-2 inhibition by Trichinella spiralis.

Authors:  Ka Bian; Meng Zhong; Yael Harari; Mildred Lai; Norman Weisbrodt; Ferid Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-01       Impact factor: 11.205

Review 5.  Bioanalytical profile of the L-arginine/nitric oxide pathway and its evaluation by capillary electrophoresis.

Authors:  Dmitri Y Boudko
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-02-15       Impact factor: 3.205

6.  Acute immune and non-immune inflammatory response in spontaneously hypertensive rats and normotensive rats. Role of endogenous nitric oxide.

Authors:  A A Ferreira; F H Kwasniewski; T C Delani; M G Torres; M A Silva; S M Caparroz-Assef; R K N Cuman; C A Bersani-Amado
Journal:  Inflammation       Date:  2007-07-31       Impact factor: 4.092

7.  Neither neutrophils nor reactive oxygen species contribute to tissue damage during Pneumocystis pneumonia in mice.

Authors:  Steve D Swain; Terry W Wright; Peter M Degel; Francis Gigliotti; Allen G Harmsen
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 8.  Nitric oxide in the gastrointestinal tract: opportunities for drug development.

Authors:  John L Wallace
Journal:  Br J Pharmacol       Date:  2018-12-03       Impact factor: 8.739

9.  The tamoxifen derivative ridaifen-B is a high affinity selective CB2 receptor inverse agonist exhibiting anti-inflammatory and anti-osteoclastogenic effects.

Authors:  Lirit N Franks; Benjamin M Ford; Toshifumi Fujiwara; Haibo Zhao; Paul L Prather
Journal:  Toxicol Appl Pharmacol       Date:  2018-06-12       Impact factor: 4.219

Review 10.  Potential role of nitric oxide synthase isoforms in pathophysiology of neuropathic pain.

Authors:  Abhilasha Ahlawat; Ajay Rana; Nidhi Goyal; Saurabh Sharma
Journal:  Inflammopharmacology       Date:  2014-08-06       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.